Joshua is a registered patent agent with a background in molecular biology. He focuses his practice on drafting and prosecuting US patents for clients in the life sciences industries.

Prior to joining Mintz, Joshua was a postdoctoral research fellow at Harvard Medical School, where he managed a research program using gene-editing and single-cell genomics to assess factors controlling intestinal stem cell proliferation. He designed CRISPR/Cas9 knockout models to study the function of a DNA-binding protein, Zrf1, and its genetic interactions with RISC components. Additionally, Joshua participated in collaborative efforts to develop and validate computational methods for evaluating and prioritizing hypotheses generated from single-cell genomics data. He was also awarded a Croucher Fellowship for Postdoctoral Research for early-career Hong Kong researchers focusing on natural sciences, technology, or medicine. 

While earning his PhD at the University of Queensland, Joshua characterized the function and regulation of the cell adhesion molecule, Dscam2, in the context of neurodevelopment. Using an endogenous splicing reporter, he identified Muscleblind as a regulator of cell-type-specific alternative splicing. During his graduate and undergraduate studies, Joshua also served as a teaching assistant.